Bossuyt, Peter
Pouillon, Lieven
Peyrin-Biroulet, Laurent
Article History
First Online: 25 January 2017
Competing interests
: P.B. is part of the advisory board for Dr Falk Benelux, Hospira, Janssens-Cilag, MSD, Mundipharma, Pfizer, Roche and Takeda, has received lecture fees from Abbvie, Takeda and Vifor Pharma, and has received an educational grant from Abbvie. L.P.-B. has received consulting fees from Abbvie, Amgen, Biogaran, BMS, Boerhinger-Ingelheim, Celgene, Celltrion, Ferring, Forward Pharma, Genentech, HAC-Pharma, Hospira, Index Pharmaceuticals, Janssen, Lilly, Merck, Mitsubishi, Norgine, Pfizer, Pharmacosmos, Pilège, Sandoz, Takeda, Therakos, Tillots, UCB-pharma and Vifor; received lecture fees from Merck, Abbvie, Takeda, Janssen, Takeda, Ferring, Norgine, Tillots, Vifor, Therakos, Mitsubishi, HAC-pharma. L.P. declares no competing interests.